PLUS1
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Verrica Parmaceuticals Inc | VRCA | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 0.32 | 2.02% | 16.20 | 16.20 | 15.60 | 15.97 | 15.88 | 15:18:55 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 16.05 | 16.20 | 0.15 | 0.93% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 758 | 45,715 | $ 15.90 | $ 726,795 | 87,902 | 6.84 - 18.67 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 15:19:51 | 76 | $ 16.07 | USD |
Verrica Parmaceuticals Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 417.56M | 25.78M | $ -20.65M | -1.48 | - | 14.69M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Verrica Parmaceuticals News
| Date | Time | Source | News Article |
|---|---|---|---|
| 1/16/2020 | 16:11 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 11/27/2019 | 07:00 | GlobeNewswire Inc. | Verrica Pharmaceuticals Announces FDA Filing Acceptance of.. |
| 11/25/2019 | 07:00 | GlobeNewswire Inc. | Verrica Pharmaceuticals Announces Participation in the Piper.. |
| 11/20/2019 | 17:02 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 11/19/2019 | 07:00 | GlobeNewswire Inc. | Verrica Pharmaceuticals Announces Passing of Board of.. |
| 11/06/2019 | 17:06 | Edgar (US Regulatory) | Quarterly Report (10-q) |
| 11/06/2019 | 16:19 | Edgar (US Regulatory) | Current Report Filing (8-k) |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical VRCA Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 14.60 | 16.3978 | 14.50 | 15.50 | 60,253 | 1.60 | 10.96% |
| 1 Month | 15.44 | 17.21 | 14.14 | 15.51 | 65,577 | 0.76 | 4.92% |
| 3 Months | 13.60 | 18.67 | 12.60 | 15.03 | 73,163 | 2.60 | 19.12% |
| 6 Months | 10.75 | 18.67 | 8.39 | 14.12 | 62,441 | 5.45 | 50.7% |
| 1 Year | 10.48 | 18.67 | 6.84 | 12.77 | 56,163 | 5.72 | 54.58% |
| 3 Years | 20.00 | 23.29 | 6.44 | 13.67 | 59,744 | -3.80 | -19.0% |
| 5 Years | 20.00 | 23.29 | 6.44 | 13.67 | 59,744 | -3.80 | -19.0% |
Verrica Parmaceuticals Description
| Verrica Pharmaceuticals Inc a clinical-stage biopharmaceutical company. The company is primarily focused on identifying, developing and commercializing pharmaceutical products for the treatment of skin diseases with unmet needs. Its pipeline product includes NCT03377803, and NCT03377790. |
